Imovane

Zopiclone, the active ingredient in Imovane, is a cyclopyrrolone (non‑benzodiazepine hypnotic) presented as an oral tablet for oral use. It is prescribed for the short‑term treatment of insomnia in adults who have difficulty falling or staying asleep.

GNH USA supplies Imovane as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company follows strict quality standards to ensure reliable sourcing for regulated markets. It also provides comprehensive regulatory support and efficient, timely delivery across global regions.

Zopiclone acts on the central nervous system to promote sleep in patients with insomnia.

Insomnia (short‑term): improves sleep onset and maintenance in adults with transient sleep disturbance. Sleep onset insomnia: reduces the time required to fall asleep during the first night of treatment. Sleep maintenance insomnia: decreases nocturnal awakenings and prolongs total sleep time. Elderly patients with insomnia: provides a sleep aid with careful monitoring for falls. Acute stress‑related insomnia: offers temporary relief under medical supervision.

Zopiclone may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Drowsiness: feeling of sleepiness during the day. - Dry mouth: reduced salivary flow causing discomfort. - Headache: mild to moderate cranial pain. - Dizziness: sensation of light‑headedness or unsteadiness.

Serious or Rare Side Effects: - Complex sleep behaviours: activities such as sleep‑walking or sleep‑driving. - Allergic reactions: rash, swelling, or difficulty breathing. - Depression or suicidal thoughts: mood changes requiring immediate medical attention.

Zopiclone should be used with caution and according to medical guidance. - Use only as prescribed: limit therapy to short periods to reduce dependence risk. - Avoid alcohol: concurrent use may intensify sedation and respiratory depression. - Caution in elderly: increased susceptibility to falls and cognitive impairment. - Assess renal and hepatic function: dose adjustment may be required in impairment. - Do not operate machinery or drive: residual effects can impair alertness. - Store at ambient temperature: keep in original packaging, protect from moisture.

Zopiclone can interact with other substances that affect the central nervous system.

Major Interactions (Avoid): - Alcohol: additive central nervous system depression. - Opioids: heightened risk of respiratory depression. - Other sedative hypnotics (e.g., benzodiazepines): excessive sedation.

Moderate Interactions (Monitor Closely): - CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): may increase plasma concentrations. - CYP3A4 inducers (e.g., rifampicin, carbamazepine): may reduce effectiveness. - Antihistamines (e.g., diphenhydramine): may enhance sedative effect.